ONO Pharmaceutical is focused on the production, purchase, and sale of pharmaceuticals and diagnostic reagents on prescription pharmaceuticals. The company focuses on drug discovery leads that are high in certainty and globally competitive. The company was started in 1717 in Dosho-machi, Osaka. Throughout its 300-year history, ONO has dedicated itself to developing innovative and breakthrough pharmaceutical products.

The Institute Pasteur is a private, non-profit foundation. Its mission is to help prevent and treat diseases, mainly those of infectious origin, through research, teaching, and public health initiatives.The Institut Pasteur is a research center of international renown ideally located in the very heart of Paris. Each year the institute hosts a multitude of scientific and medical conferences and meetings as well as events on a variety of themes.

Far East Super Laboratories Ltd. is a private company headquartered in China that operates testing laboratories.

American Cyanamid Company was a U.S.-based diversified company with businesses in several fields. The company was a manufacturer of agricultural chemicals, cosmetics, perfumes, building products, plastics and pharmaceuticals. The company was listed as a top 100 manufacturing company by Fortune magazine in the 1970s. Cyanamid was founded in 1907 and employed over 100,000 people around the world by 2000. The company maintained a monopoly over tetracycline, an antibiotic used against bacterial infections. A theft of the organism led to the loss of the monopoly as rival companies were able to produce generic versions of the formula, leading to huge losses to the company. The company sold most of its businesses in the early 2000s and is now operated under the name Cytec.  

STERIS, Inc., a subsidiary of STERIS Plc (Ireland), is a company headquartered in the United States specializing in orthopedic, prosthetic, and surgical appliances and supplies.

Versitech Ltd. is a Hong Kong Chinese company located in Hong Kong and ultimately controlled by the Government of Hong Kong Special Administrative Region. The firm provides business services.

Eiken Chemical Co., Ltd. engages in the manufacture and sale of clinical diagnostics products and equipment. It operates through following business divisions: Clinical Diagnostics and Testing of Food and Environment. The Clinical Diagnostics division handles the manufacture of clinical diagnostic products and services. The Testing of Food and Environment division deals with the sale of reagents for microbiological tests on food for poisoning bacteria, and environment for contamination of work environments. Its products include fecal immunochemical testing equipment, molecular test loop-mediated isothermal amplification (LAMP), immunological and serological reagents, and rapid diagnostic tests such as IMMUNOCATCH Norovirus, IMMUNOCATCH Legionella, and IMMUNOCATCH Streptococcus pneumoniae. The company was founded on February 20, 1939 and is headquartered in Tokyo, Japan.

Gemmus Pharma Inc. develops pharmaceutical products for the treatment of infectious diseases. The firm focus on the development of pharmaceutical products for the treatment of influenza and other viral infectious diseases. It develops GP1001, a non-peptidic eiconsanoid analog that is used for the treatment of serious influenza infections that require hospitalization as either a stand-alone treatment or co-therapy with an antiviral drug, as oseltamivir. The company was founded by Daryl H. Faulds in 2007 and is headquartered in San Francisco, CA.

Novartis Vaccines & Diagnostics, Inc. manufactures and markets health care and nutritional products. The company was founded in 1986 and is headquartered in East Hanover, NJ.

Chiron Corporation (/ˈkaɪrɒn/ KY-ron) was an American multinational biotechnology firm based in Emeryville, California that was acquired by Novartis on April 20, 2006. It had offices and facilities in eighteen countries on five continents. Chiron's business and research was in three main areas: biopharmaceuticals, vaccines, and blood testing. Chiron's vaccines and blood testing units were combined to form Novartis Vaccines and Diagnostics, while Chiron BioPharmaceuticals was integrated into Novartis Pharmaceuticals. In 2014, Novartis completed the sale of its blood transfusion diagnostics unit to Grifols and announced agreements for the sale of its vaccines unit to GlaxoSmithKline.

Protein Sciences was founded in 1983 and has over 30 years of experience in developing vaccines and biopharmaceuticals for the prevention and treatment of a variety of diseases. They use their proprietary BEVS protein expression technology to produce high quality recombinant proteins quickly, reliably and at low cost.

Vical, Inc. engages in the research and development of biopharmaceutical products based on patented DNA delivery technologies for the prevention and treatment of serious and life-threatening diseases. It focuses on the antifungal VL-2397, which treats patients with invasive aspergillosis. Its products include Vaxfectin, a cationic lipid formulation optimized to increase the immune response to vaccines. The company was founded by Howard E. Greene, Jr. Timothy J. Wollaeger, Karl Y. Hostetler, and Douglas D. Richman in April 1987 and is headquartered in San Diego, CA.

Korea Research Institute of Bioscience and Biotechnology (KRIBB) is a government research institute in Daejeon, South Korea. It is dedicated to biotechnology research across a broad span of expertise, from basic studies for the fundamental understanding of life phenomena to applied studies such as drug discovery, novel biomaterials, integrated biotechnology and bioinformation.

Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. It operates through the Ionis Core segment. The Ionis Core segment exploits a novel drug discovery platform to generate a pipeline of drugs. The company was founded by Stanley T. Crooke, David J. Ecker, Christopher K. Mirabelli, and Brett P. Monia in 1989 and is headquartered in Carlsbad, CA.

Adaltis, Inc. is an international in-vitro diagnostic company. The company develops, manufactures and markets in-vitro diagnostic systems and reagent products to detect viral infections, diagnose immune system diseases and measure human hormone responses. Adaltis was founded on June 12, 1987 and is headquartered in Montreal, Canada.